Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRKR Marker Therapeutics, Inc.

盘前交易 02-10 05:36:20 EST

1.48

-0.17

-10.30%

最高1.65	最低1.46	成交量45.11万
今开1.63	昨收1.65	日振幅11.52%
总市值2,468万	流通市值2,090万	总股本1,667万
成交额68.03万	换手率3.19%	流通股本1,412万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRKR","market":"US","secType":"STK","nameCN":"Marker Therapeutics, Inc.","latestPrice":1.48,"timestamp":1770670800000,"preClose":1.65,"halted":0,"volume":451119,"delay":0,"changeRate":-0.10303030303030299,"floatShares":14120600,"shares":16673100,"eps":-1.17,"marketStatus":"盘前交易","change":-0.17,"latestTime":"02-10 05:36:20 EST","open":1.63,"high":1.65,"low":1.46,"amount":680337.6164328001,"amplitude":0.115152,"askPrice":2.08,"askSize":100,"bidPrice":1.4,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.17,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.48,"postHourTrading":{"tag":"盘后","latestPrice":1.4801,"preClose":1.48,"latestTime":"19:53 EST","volume":2983,"amount":4441.0067,"timestamp":1770684828650,"change":0.0001,"changeRate":0.000068,"amplitude":0.006757},"volumeRatio":1.6263209914140582,"impliedVol":3.5652,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/MRKR","defaultTab":"news","newsList":[{"id":"2593343466","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.47%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593343466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593343466?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:56","pubTimestamp":1766419011,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日23时56分，Marker Therapeutics, Inc.股票出现异动，股价快速拉升5.47%。截至发稿，该股报1.35美元/股，成交量11.3981万股，换手率0.68%，振幅4.69%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤学公司，专门从事用于治疗血液系统恶性肿瘤和实体瘤适应症的新型基于 T 细胞的免疫疗法和基于肽的疫苗的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122223565197a08eaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122223565197a08eaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"1115518628","title":"Marker Therapeutics, Inc.：现有现金、现金等价物及受限现金将支持运营开支至2026年第三季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1115518628","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115518628?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:19","pubTimestamp":1763122778,"startTime":"0","endTime":"0","summary":"Marker Therapeutics, Inc.：现有现金、现金等价物及受限现金将支持运营开支至2026年第三季度","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MRKR"],"gpt_icon":0},{"id":"1198622667","title":"Marker Therapeutics, Inc.公布1期Apollo研究更新数据，复发性淋巴瘤总体缓解率令人鼓舞","url":"https://stock-news.laohu8.com/highlight/detail?id=1198622667","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198622667?lang=zh_cn&edition=full","pubTime":"2025-08-26 19:01","pubTimestamp":1756206093,"startTime":"0","endTime":"0","summary":"Marker Therapeutics, Inc.公布1期Apollo研究更新数据，复发性淋巴瘤总体缓解率令人鼓舞","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MRKR"],"gpt_icon":0},{"id":"2556138242","title":"Marker Therapeutics, Inc.盘中异动 快速跳水5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556138242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556138242?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314350,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，Marker Therapeutics, Inc.股票出现异动，股价急速跳水5.56%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤学公司，专门从事用于治疗血液系统恶性肿瘤和实体瘤适应症的新型基于 T 细胞的免疫疗法和基于肽的疫苗的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213230a6d28339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213230a6d28339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","MRKR","BK4139","BK4007"],"gpt_icon":0},{"id":"2518203028","title":"Marker Therapeutics, Inc.盘中异动 早盘急速拉升5.33%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518203028?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613645,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分，Marker Therapeutics, Inc.股票出现异动，股价快速拉升5.33%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2517948357","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨9.42%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948357?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185126,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Marker Therapeutics, Inc.股票出现波动，股价急速上涨9.42%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206a260c78a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206a260c78a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2517997902","title":"Marker Therapeutics(MRKR.US)获加拿大投资银行集团首次覆盖，给予买入评级, 目标价8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517997902","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517997902?lang=zh_cn&edition=full","pubTime":"2025-03-05 18:56","pubTimestamp":1741172193,"startTime":"0","endTime":"0","summary":"Marker Therapeutics(MRKR.US)获加拿大投资银行集团首次覆盖，给予买入评级, 目标价8.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05185648544417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRKR","LENZ"],"gpt_icon":0},{"id":"2514334834","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514334834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514334834?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:26","pubTimestamp":1740684361,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时26分，Marker Therapeutics, Inc.股票出现波动，股价大幅上涨5.23%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280326019895468b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280326019895468b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2514773003","title":"Marker Therapeutics, Inc.盘中异动 早盘快速跳水5.52%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514773003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514773003?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:57","pubTimestamp":1740412640,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时57分，Marker Therapeutics, Inc.股票出现异动，股价快速下跌5.52%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235720abdb2246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235720abdb2246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2513211213","title":"Marker Therapeutics, Inc.盘中异动 快速跳水5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513211213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513211213?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:36","pubTimestamp":1740166584,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时36分，Marker Therapeutics, Inc.股票出现波动，股价快速下挫5.52%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222033624962bbc90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222033624962bbc90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2511574215","title":"Marker Therapeutics, Inc.盘中异动 急速拉升8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511574215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511574215?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:19","pubTimestamp":1739477980,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时19分，Marker Therapeutics, Inc.股票出现波动，股价大幅拉升8.18%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021404194098846fa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021404194098846fa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2510286372","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510286372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510286372?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:35","pubTimestamp":1739198126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时35分，Marker Therapeutics, Inc.股票出现波动，股价急速上涨7.47%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223527961e00ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223527961e00ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2509205868","title":"Marker Therapeutics, Inc.盘中异动 早盘急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509205868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509205868?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:00","pubTimestamp":1738857623,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时00分，Marker Therapeutics, Inc.股票出现波动，股价快速下跌5.20%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207000023a23be246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207000023a23be246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2509380062","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509380062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509380062?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:37","pubTimestamp":1738769837,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时37分，Marker Therapeutics, Inc.股票出现波动，股价大幅上涨5.94%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233717abc38c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233717abc38c2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2509491992","title":"Marker Therapeutics, Inc.盘中异动 临近收盘快速拉升5.03%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509491992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509491992?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:49","pubTimestamp":1738702198,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时49分，Marker Therapeutics, Inc.股票出现异动，股价大幅拉升5.03%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205044959987a842f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205044959987a842f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2508144355","title":"Marker Therapeutics, Inc.盘中异动 股价大跌9.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508144355?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:45","pubTimestamp":1738593941,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时45分，Marker Therapeutics, Inc.股票出现波动，股价大幅下跌9.07%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224542987971a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224542987971a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2507624413","title":"Marker Therapeutics, Inc.盘中异动 早盘快速拉升9.03%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507624413?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:47","pubTimestamp":1738248457,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时47分，Marker Therapeutics, Inc.股票出现异动，股价快速上涨9.03%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302247389876b3ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302247389876b3ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2506168302","title":"Marker Therapeutics, Inc.盘中异动 临近午盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506168302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506168302?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:46","pubTimestamp":1737996380,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时46分，Marker Therapeutics, Inc.股票出现异动，股价快速下挫5.14%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004621abba7c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004621abba7c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2505043909","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505043909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505043909?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:12","pubTimestamp":1737648735,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时12分，Marker Therapeutics, Inc.股票出现波动，股价大幅拉升5.05%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001216abb60ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001216abb60ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2504112815","title":"Marker Therapeutics, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504112815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504112815?lang=zh_cn&edition=full","pubTime":"2025-01-18 04:48","pubTimestamp":1737146902,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日04时48分，Marker Therapeutics, Inc.股票出现异动，股价快速下挫5.26%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180448239607e35f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180448239607e35f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.markertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1345},{"period":"1month","weight":-0.26},{"period":"3month","weight":0.5885},{"period":"6month","weight":0.1473},{"period":"1year","weight":-0.1638},{"period":"ytd","weight":-0.0067}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marker Therapeutics, Inc.是一家临床阶段的免疫肿瘤学公司，专门开发下一代T细胞免疫疗法，用于治疗血液系统恶性肿瘤和实体肿瘤适应症。 Marker的细胞治疗技术基于非工程化的肿瘤特异性T细胞的选择性扩增，其识别肿瘤相关抗原（即肿瘤靶标）并杀死表达这些靶标的肿瘤细胞。一旦输入患者，这组T细胞攻击多个肿瘤靶标并起到激活患者免疫系统的作用，以产生广谱抗肿瘤活性。由于Marker不对其T细胞进行基因工程改造，因此与目前基于CAR-T和TCR的工程方法相比，其产品（i）的成本更低，更容易制造，（ii）毒性明显降低，（ iii）与有意义的临床益处相关。因此，与当前基因修饰的CAR-T和基于TCR的疗法相比，Marker认为其T细胞疗法组合具有引人注目的治疗产品特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055182},{"month":2,"riseRate":0.3,"avgChangeRate":-0.076284},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.080323},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.002513},{"month":5,"riseRate":0.555556,"avgChangeRate":0.241279},{"month":6,"riseRate":0.555556,"avgChangeRate":0.258108},{"month":7,"riseRate":0.111111,"avgChangeRate":-0.078392},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.035761},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.06731},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.021955},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.047609},{"month":12,"riseRate":0.3,"avgChangeRate":0.054056}],"exchange":"NASDAQ","name":"Marker Therapeutics, Inc.","nameEN":"Marker Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marker Therapeutics, Inc.,MRKR,Marker Therapeutics, Inc.股票,Marker Therapeutics, Inc.股票老虎,Marker Therapeutics, Inc.股票老虎国际,Marker Therapeutics, Inc.行情,Marker Therapeutics, Inc.股票行情,Marker Therapeutics, Inc.股价,Marker Therapeutics, Inc.股市,Marker Therapeutics, Inc.股票价格,Marker Therapeutics, Inc.股票交易,Marker Therapeutics, Inc.股票购买,Marker Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}